UCB is building a new U.S. biologics manufacturing facility in Gwinnett County, Georgia. The state-of-the art campus will leverage AI, robotics, and automation. The project is part of UCB’s previously announced U.S. expansion and long-term commitment growth in the U.S. market. The 460,000 sq.-ft. campus will sit on 79 acres and is designed to be a cornerstone of UCB’s global biologics manufacturing network. Once operational, the facility is expected to produce complex biologics 24/7 primarily...